Mass Spectrometry Products in Clinical Diagnostics

Accurately quantify trace analytes in a clinical diagnostic lab with the MassTrak ACQUITY UPLC I-Class PLUS/Xevo TQ-XS IVD System.

High-performance mass spectrometry technology that brings ultimate sensitivity and speed to clinical diagnostics laboratories. SCIEX Citrine system is an in vitro diagnostic medical device that provides you with the highest performance and reliability to tackle today’s difficult assays, and the versatility to address tomorrow’s challenges. Delivering the legendary robustness and reliability of a SCIEX mass spectrometry solutio…

The 4500MD delivers rugged performance, sensitivity and rapid data acquisition for clinical labs that want to improve the quality of diagnostic testing, develop their own assays and perform routine tests with high efficiency and improved return on investment.

As an alternative to conventional columns, PharmaFluidics offers micromachined nano-LC columns or micro Pillar Array Columns (µPAC™). These µPAC™ columns display exceptional separation properties with unprecedented peak capacity and narrow peak shapes at low operating back-pressure. µPAC™ column, 200 cm length, with pillar array backbone at interpillar distance of 2.5µm, C18.

Unleash your performance with RMX GC Columns - enhanced detection, less down time & more discovery.

For mid-to-high volume labs, the G11 delivers a comprehensive HbA1c and ẞ-thalassemia testing solution, offering high throughput without compromising quality, helping clinicians work smarter and faster, and ultimately enhancing patient care.

Set a new benchmark in lab efficiency with the HLC-723 GR01 analyzer, which combines intuitive operation and robust reliability. It delivers one of the fastest hemoglobin separation methods available, ensuring consistent and accurate HbA1c results. Beyond diabetes care, GR01 adds clinical value through precise detection of hemoglobin variants, maximizing performance and ROI.

Tosoh Automated Glycohemoglobin Analyzer HLC-723 GX is part of the Tosoh family that continues to set the standard for diabetes monitoring and diagnosis worldwide. The HLC-723GX offers the quality that you would expect from a Tosoh system and is ideal for all low volume test settings. Tosoh, expert in separation, offers scalable solution and genuine confidence.

Prep your samples, dry them on your LazWell plate, stack ‘em in the Luxon and start it. Best part is, there are virtually no false positives when using the LDTD technology, so it’s the perfect alternative to your EIA high-throughput screening methods. Wanna do it even faster? With our Luxon-HTS model, you can go below 1 second per sample. Talk about high-speed analysis!

Stable Isotope-labeled Standards for Clinical Mass Spectrometry

Enzymatic digestion of proteins in polyacrylamide gel slices and subsequent analysis of the peptides by mass spectrometry has become a routine procedure in protein analysis. In solution digestion protocols for bottom-up proteomics complement it. The DigestPro MSi automates all those procedures to achieve high throughput under controlled and reproducible conditions.

With an internal volume of 3µL, this 50 cm long RP-C18 µPAC™ column is perfectly suited to perform high throughput analyses with shorter gradi­ent solvent times (30, 60 and 90-minute gradients) and it can be used over a wide range of flow rates, between 100 and 2000 nL/min. µPAC™ column, 50 cm length, with pillar array backbone at interpillar distance of 2.5µm, C18.

Our µPAC™ Trapping column was developed with an identical stationary phase support morphology, matching perfectly the retentive properties of our analytical µPAC™ columns. Effectively desalting and preconcentrating the analytes improves the analytical column lifetime and workflow throughput.

The µPAC™ capLC columns are designed for increased robustness and throughput assuring sensitivity. A flow rate versatility between 1 and 15 µL/min at moderated pressures allows short gradient separations, while the µPAC™ technology ensures an exceptional high reproducibility over time and across laboratories. µPAC™ column, 50cm length, with pillar array backbone at interpillar distance of 2.5 µm, C18.

Target Sufficiency® is the ability of a target system to respond to a therapeutic. It reflects the abundance and forms of the drug target protein, as well as other key system proteins that connect the target to disease phenotypes and enable response. Assessment of the target system requires an analysis platform that can simultaneously capture multiple precise protein measurements.